[HTML][HTML] Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study
ML Andersen, FD Zegers, LR Jølving… - Multiple Sclerosis and …, 2023 - Elsevier
Background It has not previously been clarified if COVID-19 triggers disease activity and
increases the risk of hospitalisation with COVID-19 in patients with multiple sclerosis. We …
increases the risk of hospitalisation with COVID-19 in patients with multiple sclerosis. We …
SARS-CoV-2 and the nervous system
A Kułakowska - Neurologia i Neurochirurgia Polska, 2023 - journals.viamedica.pl
As guest editor of the current issue of Leading Topic published in the Polish Journal of
Neurology and Neurosurgery, I am pleased to present a series of articles regarding the …
Neurology and Neurosurgery, I am pleased to present a series of articles regarding the …
[PDF][PDF] Is disease-modifying therapy use in the multiple sclerosis a risk factor during the COVID-19 pandemic? A large cohort study
2-Dokuz Eylul University, Graduate School of Health Sciences, Department of
Neurosciences, Izmir, Turkey; Urla State Hospital, Department of Neurology, Izmir, Turkey 3 …
Neurosciences, Izmir, Turkey; Urla State Hospital, Department of Neurology, Izmir, Turkey 3 …
[PDF][PDF] Multiple Sclerosis and Related Disorders
FE van der Feen, GA de Haan, I van der Lijn… - core.ac.uk
Background: Multiple sclerosis (MS) can manifest itself in many ways, all of which can affect
the independent outdoor mobility of persons with MS (pwMS). In most studies, mobility of …
the independent outdoor mobility of persons with MS (pwMS). In most studies, mobility of …